Westborough, MA site production capacity increased to support biopharma industry growth

USD 7 million investment in single-use manufacturing capabilities supports improved performance, quality and security of supply

CHALFONT ST. GILES, UK – GE Healthcare’s Life Sciences business, a global provider of expertise, tools and technologies to the biotech industry, announced today a USD 7 million expansion project at its single-use technology manufacturing facility in Westborough, MA, US. The expanded site will manufacture a range of single-use products, including cell growth bags, based on a newly developed film platform resulting from GE’s strategic alliance with Sealed Air.

With global demand predicted to exceed USD 3 billion by 20201, single-use bioprocessing technologies are playing an increasingly vital role to biologic producers, helping them accelerate capacity expansion and improve productivity to support faster delivery of targeted therapies to patient populations. GE’s tripling of